CLPBF(CLPBF)
CLPBF
No analyst ratings available
No analyst price targets available for CLPBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.37B | $31.35B | $33.37B | $35.93B | $38.43B |
| Low | $29.14B | $30.88B | $32.99B | $35.52B | $38.00B |
| High | $29.57B | $31.91B | $33.79B | $36.38B | $38.92B |
| EBITDA Avg | $9.46B | $10.10B | $10.76B | $11.58B | $12.39B |
| Low | $9.39B | $9.95B | $10.63B | $11.45B | $12.25B |
| High | $9.53B | $10.28B | $10.89B | $11.73B | $12.54B |
| EBIT Avg | $8.16B | $8.71B | $9.27B | $9.99B | $10.68B |
| Low | $8.10B | $8.58B | $9.17B | $9.87B | $10.56B |
| High | $8.22B | $8.87B | $9.39B | $10.11B | $10.82B |
| Net Income Avg | $5.79B | $6.03B | $6.52B | $7.33B | $7.79B |
| Low | $5.29B | $5.94B | $6.42B | $7.22B | $7.68B |
| High | $6.86B | $6.13B | $6.62B | $7.45B | $7.92B |
| EPS Avg | $25.69 | $26.77 | $28.92 | $32.51 | $34.58 |
| Low | $23.47 | $26.37 | $28.49 | $32.03 | $34.07 |
| High | $30.43 | $27.21 | $29.39 | $33.04 | $35.14 |
| Analysts (Rev / EPS) | 20 / 11 | 20 / 7 | 9 / 9 | 10 / 9 | 10 / 4 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $7.50B | $7.56B |
| Low | $7.37B | $7.42B |
| High | $7.60B | $7.66B |
| EBITDA Avg | $2.42B | $2.44B |
| Low | $2.37B | $2.39B |
| High | $2.45B | $2.47B |
| EBIT Avg | $2.08B | $2.10B |
| Low | $2.05B | $2.06B |
| High | $2.11B | $2.13B |
| Net Income Avg | $1.28B | $1.58B |
| Low | $1.25B | $1.55B |
| High | $1.30B | $1.61B |
| EPS Avg | $5.66 | $7.03 |
| Low | $5.53 | $6.87 |
| High | $5.76 | $7.15 |
| Analysts (Rev / EPS) | 8 / 1 | 5 / 1 |